Keapstone Board of Directors meeting

Keapstone Therapeutics, the single-asset virtual biotech created by University of Sheffield with funding from Parkinson’s UK, held a board meeting on 15 May 2017 in Sheffield.

The board took decisions on the strategy for funding of future stages of the research programme, and provided guidance to the Joint Steering Committee on medium-term research directions. The board also agreed that a website for Keapstone should be created.